Celebrating One Year of Spot On CML
In its inaugural year, Spot On CML brought free innovative diagnostic tests to 371 patients across 15 countries.
These tests are critically important because a confirmed diagnosis is required for a patient to begin receiving free treatment through our donation programs – and access to treatment is access to life.
We extend our deepest thanks to the dedicated team at Fred Hutch and the hundreds of physicians and nurses around the world who work tirelessly to support their patients. Thanks to your efforts, we not only met but exceeded our initial goal – testing one new patient per day for an entire year.
Here’s how the patient numbers break down by country:
- Bhutan – 5
- Cambodia – 2
- Cote d’Ivoire – 10
- East Timor – 3
- Fiji – 5
- Honduras – 40
- Kenya – 7
- Mexico – 30
- Mongolia – 21
- Nepal – 95
- Niger – 18
- Nigeria – 10
- Philippines – 17
- Tajikistan – 50
- Uganda – 58
About Spot On CML
Launched in 2017, Spot On CML is a groundbreaking collaboration between The Max Foundation and Fred Hutchinson Cancer Research Center (Fred Hutch) to increase access to testing for chronic myeloid leukemia (CML) patients in under-resourced countries. The initiative utilizes a special process developed by Fred Hutch researcher and The Max Foundation board member Dr. Jerry Radich. In it, paper test cards are spotted with dried blood samples and mailed to Fred Hutch from all over the world, where researchers perform testing on the samples free-of-charge.
The Max Foundation is a global health organization that believes all people living with cancer have the right to access the best treatment and support. Through personalized access services, quality training and education, and global advocacy efforts, we aim to help people face cancer with dignity and hope.
###
